Revance Therapeutics develops neuromodulators and dermal fillers for the premium aesthetics market, with possible therapeutic uses for muscle movement and pain disorders. Its injectable products are used by healthcare professionals to reduce wrinkles and restore facial volume, improving patient outcomes. The company stands apart by pairing a portfolio of cosmetic injectables with HintMD, a fintech platform that streamlines payments and clinic management for aesthetic practices. Its goal is to lead the premium aesthetics space by offering differentiated injectables and expanding fintech-enabled services for practice efficiency.
Company Size
501-1,000
Company Stage
IPO
Headquarters
Nashville, Tennessee
Founded
1999
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?